WallStreetZenWallStreetZen

NASDAQ: BRNS
Barinthus Biotherapeutics Revenue

OverviewForecastEarningsRevenue
DividendOwnership
Barinthus Biotherapeutics revenue was $14.97M for the trailing 12 months ending Dec 31, 2024, with N/A growth year over year. Quarterly revenue for the quarter (Q4 2024) ending on Dec 31, 2024 was $0.0, down 100% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, BRNS annual revenue was $15.0M, with 1,766.5% growth year-over-year.

BRNS past revenue growth

How has BRNS's revenue growth performed historically?

Company
1,766.46%
Industry
420.79%
Market
20.33%
BRNS's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
BRNS's revenue has grown faster... subscribe to Premium to read more.
Revenue Growth vs Market Performance
BRNS's revenue growth is accelerating... subscribe to Premium to read more.
Accelerating Revenue Growth Performance

BRNS revenue history

Current Revenue
$15.0M
Current Earnings
-$61.1M
Current Profit Margin
-408%

Be the first to know when BRNS announces revenue.

BRNS Revenue History By Year

BRNS Yearly RevenueBRNS RevenueBRNS ChangeBRNS Revenue Growth
2024-12-31$14.97M$14.17M+1,766.46%
2023-12-31$802.00k-$43.90M-98.21%
2022-12-31$44.70M$44.44M+16,580.22%
2021-12-31$268.00k-$4.55M-94.44%
2020-12-31$4.82M-$2.02M-29.57%
2019-12-31$6.85MN/AN/A

1 of 1

Barinthus Biotherapeutics Revenue FAQ

What was BRNS's revenue last quarter?

On Invalid Date, Barinthus Biotherapeutics (NASDAQ: BRNS) reported Q4 2024 revenue of $0.00 up N/A year over year. In the same quarter last year, Barinthus Biotherapeutics's revenue was $0.00.

What was Barinthus Biotherapeutics's revenue in 2024?

Barinthus Biotherapeutics's annual revenue for the twelve months ending Dec 31, 2024 was $14.97 million, a 1,766.46% increase year over year.

How much does Barinthus Biotherapeutics make in a day?

Based on Barinthus Biotherapeutics annual revenue for the past five years, BRNS makes an average of $35,924.93 per day.

What was Barinthus Biotherapeutics's annual revenue growth in the past year?

As of Q1 2025, Barinthus Biotherapeutics's revenue has grown 1,766.46% year over year. This is 1,345.67 percentage points higher than the US Biotechnology industry revenue growth rate of 420.79%. Barinthus Biotherapeutics's revenue in the past year totaled $14.97 million.

How much does Barinthus Biotherapeutics make in a year?

Barinthus Biotherapeutics's revenue by year for the past five years is:
  • Barinthus Biotherapeutics's revenue for the twelve months ending Dec 31, 2024 was $14.97 million, a 1,766.46% increase year over year.
  • Barinthus Biotherapeutics's annual revenue for Dec 31, 2023 was $802.00 thousand, a 98.21% decrease from 2022.
  • Barinthus Biotherapeutics's annual revenue for 2022 was $44.70 million, a 16,580.22% increase from 2021.
  • Barinthus Biotherapeutics's annual revenue for 2021 was $268.00 thousand, a 94.44% decrease from 2020.
  • Barinthus Biotherapeutics's annual revenue for 2020 was $4.82 million, a 29.57% decrease from 2019.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.